Kilitch Drugs (India) Limited (NSE:KILITCH)

Kilitch Drugs (India) Revenue

Kilitch Drugs (India) had revenue of 523.74M INR in the quarter ending September 30, 2026, with 7.05% growth. This brings the company's total for the last twelve months to 2.34B, up 11.88% year-over-year. In the fiscal year ending March 31, 2026, Kilitch Drugs (India) had annual revenue of 2.35B with 18.74% growth.

• Revenue (ttm): 2.34B
• Revenue Growth: +11.88%
• P/S Ratio: 2.99
• Revenue / Employee: 9.93M
• Employees: 236
• Market Cap: 6.88B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Export 1.33B 56.4%
• India 1.03B 43.5%
• Unallocated 1.26M 0.1%

Fiscal year ended Mar 31, 2026 See the full Kilitch Drugs (India) breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.35B	371.56M	18.74%
Mar 31, 2025	1.98B	439.46M	28.47%
Mar 31, 2024	1.54B	147.74M	10.58%
Mar 31, 2023	1.40B	253.65M	22.20%
Mar 31, 2022	1.14B	457.11M	66.71%

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error